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Abstract
Background Pain is undertreated in older populations. At the same time, increased use of opioids is of concern in the West-
ern world.
Aims We sought to analyze temporal trends in musculoskeletal pain and prescribed analgesic treatment among community-
dwelling people aged 75–95 years using cross-sectional cohort data spanning 20 years.
Methods The Helsinki Aging Study recruited random samples of people aged 75, 80, 85, 90, and 95 years in 1999, 2009, 
and 2019. In total, 5707 community-dwelling persons participated in the study. The participants reported their medical 
diagnoses, regular prescription medications, and the presence of back pain or joint pain within the last 2 weeks (never, 
sometimes, or daily). We compared analgesic use among participants reporting and not reporting musculoskeletal pain in 
1999, 2009, and 2019.
Results Of the participants, 57–61% reported intermittent or daily musculoskeletal pain. The percentage receiving a pre-
scribed daily analgesic increased from 9% in 1999 to 16% in 2019. The use of non-steroidal anti-inflammatory drugs 
(NSAIDs) decreased from 1999 to 2019, while the use of paracetamol increased from 2 to 11%. Opioids were taken by 2% 
in 1999 and 3% in 2019. Of those reporting daily musculoskeletal pain, 20%, 35%, and 32% received regular pain medication 
in 1999, 2009, and 2019, respectively.
Conclusions Pain remains undertreated in the community-dwelling older population, although the use of regular prescribed 
analgesics increased between 1999 and 2019. The use of NSAIDs has decreased, while the use of paracetamol has increased. 
Daily opioid use has remained modest.
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1 Introduction
Pain is a common source of suffering; up to 40% of primary 
health care visits are due to pain in the general population 
[1]. In epidemiologic studies, the prevalence of bothersome 
pain among older adults (age > 65 years) is over 50% [2, 3], 
with the back and major joints being the most common pain 
sites [1, 4–6]. Pain is undertreated in the older population [3, 
7–9] and leads to reduced social contacts and ambulation, 
sleep disturbances, symptoms of depression and anxiety, 
and increased health care use and costs [10]. However, the 
experience of pain has not decreased even though the use of 
prescription analgesics has increased in recent decades [9].
The popularity of paracetamol (acetaminophen) has 
increased while the regular use of non-steroidal anti-inflam-
matory drugs (NSAIDs) has decreased [9, 11, 12]. This is in 
accordance with the known risks of gastrointestinal bleed-
ing, hypertension, cardiovascular events, and renal failure 
associated with NSAIDs, especially among people with 
comorbidities and polypharmacy. The use of opioids has 
932 T. E. Lehti et al.
Key Points 
Pain is common and undertreated in the older population 
and leads to reduced quality of life.
Regular analgesic use increased from 1999 to 2019 
among community-dwelling people aged 75–95 years; 
however, daily musculoskeletal pain did not decrease.
Opioids were not widely used. Paracetamol use 
increased.
Respondents who reported living in long-term institu-
tional care as well as respondents who had not answered the 
questions of interest (see Sect. 2.2.2) were excluded from 
analysis.
The study design was approved by the Helsinki Univer-
sity Hospital Ethics Committee.
2.2  Measures
2.2.1  Participant Characteristics
Demographic information on education (number of years) 
and marital status was self-reported in the questionnaire 
(“Are you married or cohabiting/unmarried/divorced or 
separated/widowed?”). Age and sex were extracted from 
the participant’s Finnish personal identity code. Partici-
pants were asked to report their diagnosed diseases (yes/
no answers, 20 common diseases), from which we calcu-
lated the Charlson comorbidity index [20]. The participants 
were asked to rate their health on a four-step scale (healthy, 
moderately healthy, moderately unhealthy, very unhealthy). 
The first two options (healthy or moderately healthy) were 
categorized as good self-rated health. Functional capacity 
was assessed with a question: “Is your general condition 
such that you can move outside unaided?” (Yes/No, I need a 
walking stick or a rollator/No, I need another person’s help/
No, I cannot move outside).
2.2.2  Musculoskeletal Pain
The participants were asked whether they had experienced 
back pain that hinders activity or joint pain that hinders 
activity within the last 2 weeks on a three-step scale (never, 
sometimes, or daily).
Together with pain, we inquired about other common 
symptoms (8–10 symptoms in total, depending on the study 
year), and the participants rated the frequency of each symp-
tom on the same scale. If a participant had not given any 
answer to any of the symptoms, we considered they had not 
answered this section and excluded them from the analysis. 
On the other hand, those who had ticked at least one symp-
tom were included in the analysis and were considered not to 
have the symptoms they had not ticked. Since the back and 
the joints cover the most common sites of musculoskeletal 
pain among older adults, we used the term intermittent or 
daily musculoskeletal pain to refer to the back and/or joint 
pain the participants reported having sometimes or daily, 
respectively.
2.2.3  Analgesics Use
The participants were asked to list their regular prescription 
medications in the questionnaire. The prescribed analgesics 
increased in institutionalized settings [13] and in the gen-
eral population [14–17], raising concerns about serious risks 
associated with their use in the aging population.
Recent developments in analgesic prescribing in geriatric 
populations have not been thoroughly examined. Opioid use 
in older populations has been addressed in only a few studies 
[12, 18, 19], and overall pain management in the oldest-old 
outside institutionalized settings has received little attention. 
This study analyzed time trends in analgesics use among 
75- to 95-year-old community-dwelling persons using cohort 
data from 1999 to 2019. We compared regular analgesic use 
among people reporting daily versus intermittent musculo-
skeletal pain that hinders daily activity and among people 
not reporting musculoskeletal pain. Further, we examined 
time trends in the use of various classes of analgesics.
2  Methods
2.1  Study Design and Participants
The Helsinki Aging Study is a survey-based, cross-sectional 
cohort study that aims to monitor changes in common medi-
cal conditions, medications, symptoms, self-reported meas-
ures of wellbeing, health, and daily functioning in the com-
munity-dwelling older population in the urban Helsinki area 
in Finland (population 600,000). Random cohorts retrieved 
from the Finnish Population Information system of people 
aged 75, 80, 85, 90, and 95 years were invited to participate 
in the study in 1999, 2009, and 2019. One reminder was sent 
to non-responders. The 1999 study recruited 3921 partici-
pants. A total of 2633 participants were recruited in 2009 
and 2789 participants were recruited in 2019. One reminder 
was sent to those who had not responded to the survey. Of 
the recruited participants, 80% responded to the survey in 
1999, 73% in 2009, and 74% in 2019. The response rates are 
estimates based on how many questionnaire recipients had 
passed away, moved, or been institutionalized since the most 
recent Helsinki census.
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were classified according to the WHO Anatomical Thera-
peutic Chemical classification system. Classes M01AB 
(diclofenac), M01AE (ibuprofen, ketoprofen, naproxen), 
M01AC01 (piroxicam), and M01AX (nabumetone) were 
referred to as non-selective NSAIDs, class M01AH coxibs 
(celecoxib, etoricoxib) and M01AC06 (meloxicam) were 
referred to as selective COX2 inhibitors, class M02AA 
(topical piroxicam, diclofenac, ibuprofen, ketoprofen) were 
referred to as topical NSAIDs, while class N01A opioids 
were subdivided into weak (buprenorphine, codeine, dex-
tropropoxyphene, and tramadol) and strong opioids (metha-
done hydrochloride, morphine, fentanyl, and oxycodone). A 
combination analgesic frequently used in Finland containing 
codeine and paracetamol was classified as a weak opioid. 
Paracetamol (class N02B, other analgesics and antipyretics) 
was handled as a separate class. We excluded the follow-
ing medicines that are potentially used for pain manage-
ment from the analysis due to their various non-analgesic 
indications: antiepileptics (e.g., gabapentin, pregabalin) and 
antidepressants (e.g., duloxetine). Low-dose acetylsalicylic 
acid was not considered an analgesic in the study. We did 
not differentiate between those who took one analgesic daily 
from those taking several regular analgesics.
Only regular prescription analgesics were reported in the 
questionnaire and analyzed in this study. Over-the-counter 
analgesic use was not addressed.
2.3  Statistical Analysis
The characteristics are presented as means with standard 
deviation (SD) for continuous variables and as frequencies 
with percentages for categorical variables. Linearity across 
the three cohorts was evaluated using the Cochran–Armitage 
test (Chi-square test for trend), logistic models, and analy-
sis of variance with an appropriate contrast (orthogonal). 
When adjusting for confounding factors, a logistic regression 
model was applied; models included age, sex, and Charlson 
comorbidity index as covariates. In case of violation of the 
assumptions (e.g., non-normality) for continuous variables, 
a bootstrap-type method or Monte Carlo p values (small 
number of observations) for categorical variables were used. 
The normality of variables was evaluated graphically and 
by using the Shapiro–Wilk W test. Stata 16.1, StataCorp LP 
(College Station, TX, USA) statistical package was used for 
statistical analyses.
3  Results
Table 1 presents the cohort characteristics in 1999, 2009, 
and 2019. The number of participants eligible for analy-
sis was 2473, 1583, and 1651 in 1999, 2009, and 2019, 
respectively (total n = 5707). The percentage of women was 
highest in the first cohort in 1999 (71%) and decreased to 
69% in 2009 and 64% in 2019. The proportion of oldest-old 
participants (aged 90–95 years) was higher in 2009 and 2019 
than in 1999. The proportion of participants who received 
over 8 years of schooling increased with every study wave 
from 1999 to 2019. The proportion of widowed participants 
decreased from 1999 to 2019. The Charlson comorbidity 
index decreased from 2.1 to 1.7, while the number of pre-
scription medicines increased on average from 3.3 to 4.9.
Two in three reported being able to move outside unaided 
and the cohorts did not differ from each other in this respect. 
Most participants rated their health as good in all study 
waves; the highest percentage was 82% in 2019.
The overall percentage of people reporting musculoskel-
etal pain was 57% in 1999, 60% in 2009, and 61% in 2019. 
Approximately one quarter of participants reported daily 
pain that hinders activity (24% in 1999, 27% in 2009, and 
24% in 2019), while approximately one third of participants 
reported intermittent pain that hinders activity (33% in 1999, 
33% in 2009, and 37% in 2019). The prevalence of daily pain 
did not change from 1999 to 2019 (p = 0.67). Joint pain was 
more frequent than back pain and its prevalence increased 
from 1999 to 2019 (Table 1).
The regular use of prescription analgesics increased from 
1999 (9%) to 2019 (16%) (Table 1). Of the various analgesic 
classes, the largest increase was seen in regular paraceta-
mol use, from 2% in 1999 to 11% in 2019. The use of non-
selective NSAIDs decreased from 5% in 1999 to 2% in 2019, 
and the use of selective COX-2 inhibitors increased (but 
remained low) from 0% (n = 3) in 1999 to 1% (n = 16) in 
2019. Very few participants regularly used prescribed topical 
NSAIDs. Although the regular use of prescription opioids 
increased from 1999 to 2019, it remained low (2–4%).
From 1999 to 2019, the regular use of one or more anal-
gesics increased from 14 to 21% among those reporting mus-
culoskeletal pain and from 3 to 7% among those not report-
ing pain. Figure 1 shows the adjusted prevalence of regular 
analgesic use among people reporting intermittent or daily 
musculoskeletal pain and among those not reporting pain. 
Regular analgesic use increased in both groups from 1999 
to 2019 (p < 0.001 for cohort, p < 0.001 for pain group, 
p < 0.25 for interaction, adjusted for age, sex, and Charlson 
comorbidity index).
Among those reporting daily pain, the prevalence of 
analgesic use increased from 20% in 1999 to 32% in 2019. 
Among those reporting intermittent pain, regular analgesic 
use increased from 9% in 1999 to 14% in 2019. Figure 2 
shows the adjusted prevalence of regular analgesic use 
among people reporting intermittent or daily musculoskel-
etal pain, respectively. Both groups show an increasing trend 
between 1999 and 2019 (p < 0.001 for cohort, p < 0.001 for 
pain group, p = 0.89 for interaction, adjusted for age, sex, 
and Charlson comorbidity index).
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4  Discussion
Our study revealed that the prevalence of regular analgesic 
treatment has increased among community-dwelling older 
persons aged 75–95 years from 1999 to 2019. The use of 
paracetamol has significantly increased and is now the most 
commonly used analgesic. The use of opioids has remained 
modest. On the other hand, more than half of the participants 
reported musculoskeletal pain in 2019, and this proportion 
did not decrease since 1999. Only one third of those with 
daily pain were taking a regular analgesic prescribed by 
their doctor, suggesting continuous undertreatment of pain 
(at least with prescription drugs) in older persons.
Our findings concerning the prevalence of pain are con-
sistent with previous research, which reported the prevalence 
of pain to be approximately 52–64% in the older population 
[2–4, 8]. However, these studies are not directly compara-
ble since the definition of pain and its persistence varied 
between studies. To our knowledge, there are no previous 
studies reporting time trends in musculoskeletal pain in 
older community-dwelling populations except our prior 
report [9]. Our study suggests that the prevalence of pain 
has not decreased even after adjustment for age, sex, and 
comorbidities. Thus, the increasing proportion of the oldest 
age groups does not explain the high prevalence of pain in 
the most recent cohorts. Furthermore, even though fewer 
were widowed and more participants were better educated, 
pain remained at least as prevalent in later cohorts as in the 
first one. Consistent with previous studies, pain in the older 
population may remain undertreated [11].
In our most recent cohort from 2019, 16% of participants 
were taking regular analgesic medication prescribed by their 
doctor. This value is consistent with the 2002 AGS panel on 
persistent pain in older persons [10], in which 18% of the 
geriatric population was reported to take analgesics at least 
several times per week. The analgesic profile in our study 
consistent with recommendations on analgesic use in the 
older population [21, 22] and has improved from 1999 to 
2019; the use of paracetamol has increased while the regu-
lar use of non-selective NSAIDs has decreased. The avoid-
ance of NSAIDs may be due in part to the increased use of 
anticoagulant therapy [23]. The popularity of paracetamol 
Table 1  Cohort characteristics, prevalence of pain, and prescribed analgesics in 1999, 2009, and 2019
NSAID = non-steroidal anti-inflammatory drug, SD = standard deviation of the mean
*p for linearity. p values in square brackets are from analyses adjusted for age, sex, and the Charlson comorbidity index








Women, n (%) 1762 (71) 1089 (69) 1064 (64) < 0.001
Age, n (%) < 0.001
 75 years 701 (28) 386 (24) 405 (25)
 80 years 674 (27) 378 (24) 399 (24)
 85 years 617 (25) 349 (22) 367 (22)
 90–95 years 481 (19) 470 (30) 480 (29)
Education < 8 years, n (%) 1267 (53) 578 (37) 396 (24) < 0.001
Widowed, n (%) 1125 (47) 658 (42) 586 (36) < 0.001
Charlson comorbidity  indexa, mean (SD) 2.1 (2.0) 2.0 (1.8) 1.7 (1.6) < 0.001
Number of prescribed drugs, mean (SD) 3.3 (2.9) 4.8 (3.6) 4.9 (3.7) < 0.001
Moves outside unaided, n (%) 1582 (64) 907 (57) 1052 (64) 0.52
Good self-rated health, n (%) 1819 (77) 1150 (74) 1328 (82) < 0.001
Intermittent or daily joint or back pain within 2 
weeks, n (%)
1406 (57) 947 (60) 1006 (61) 0.007 [< 0.001]
 Back pain 979 (40) 660 (42) 698 (42)
 Joint pain 1071 (43) 749(47) 799(48)
Daily prescribed analgesic, n (%) 224 (9) 263 (17) 256 (16) < 0.001 [< 0.001]
 Non-selective NSAID 129 (5) 58 (4) 39 (2) < 0.001 [0.002]
 Selective COX-2 inhibitor 3 (0) 20 (1) 16 (1) 0.001 [0.003]
 Paracetamol 60 (2) 168 (11) 181 (11) < 0.001 [< 0.001]
 Opioid 55 (2) 67 (4) 57 (3) 0.012 [0.002]
  Weak opioid 51 (2) 58 (4) 46 (3)
  Strong opioid 5 (0) 9 (1) 12 (1)
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over other analgesics among older adults is consistent with 
a prior study [24].
The use of prescribed analgesics increased markedly from 
1999 to 2009 in our cohorts among those experiencing both 
daily as well as intermittent musculoskeletal pain. This is 
mainly due to the increased use of paracetamol. More than 
one in ten of those who reported intermittent musculoskel-
etal pain reported regular analgesic use in 2019. It may be 
questioned whether such analgesic use is appropriate. Some 
of these participants might have suffered from daily pain had 
they not taken a regular analgesic; also, they may have other 
painful conditions that our study fails to cover.
Stewart et al. [25] have recently examined analgesic use 
among community-dwelling older persons. In their study, 
28% of those with pain that lasted over 2 weeks were tak-
ing a regular analgesic. Here, we report a slightly higher 
percentage (32% in 2019) of regular analgesic use among 
people experiencing daily pain. Interestingly, 31% of those 
studied by Stewart et al. were using non-pharmacological 
strategies alone to manage their pain. The guidelines for 
treating pain in the older population emphasize that phar-
macological and non-pharmacological approaches (e.g., 
physical therapy, exercise, acupuncture) should be combined 
to achieve optimal effect [22, 26]. In fact, the underuse of 
non-pharmacological approaches may be one important rea-
son why so many older people still suffer from daily pain. 
Overall, pharmacological pain management in older adults is 
complicated by the limited selection of safe first-line analge-
sics; paracetamol is the only medicine considered generally 
safe for older persons. The use of all other analgesics (which 
are often more efficacious than paracetamol) is limited by 
the risk of serious adverse effects.
The studies reporting regular prescribed and pro re nata 
(as needed) analgesics [19] and even over-the-counter anal-
gesics [24] have shown a higher prevalence of analgesic use 
than that observed in our study. In fact, the short-term use of 
analgesics may be much more widespread than the regular 
use we investigated. However, there is evidence that a sig-
nificant proportion of older adults use prescription analge-
sics less than what is prescribed and only when the pain is 
severe [27]. Having mastery over medication use may be an 
important factor in maintaining a sense of self-efficacy [28].
Importantly, we did not observe an epidemic of regular 
opioid use among community-dwelling older persons; only 
3% of our 2019 cohort was taking opioids regularly and the 
increase from 1999 was modest. This percentage is less than 
half of what Haasum et al. [18] and Steinman et al. [12] 
reported in Sweden and in the USA. However, both of these 
studies included as-needed opioid use. Among patients with 
back pain, Enthoven et al. [24] found that almost 20% of 
older patients had taken opioids at baseline, while Taylor-
Stokes et al. [29] observed that 32–79% of patients had 






































Fig. 1  Adjusted prevalence of the regular use of prescribed anal-
gesics among participants reporting musculoskeletal pain (in black) 
and among participants not reporting musculoskeletal pain (in 
white) in 1999, 2009, and 2019. Percentages were adjusted for age, 
sex, and Charlson comorbidity index with 95% confidence intervals 
(p < 0.001 for cohort, p < 0.001 for pain group, p = 0.25 for interac-




























Fig. 2  Adjusted prevalence of the regular use of prescribed analge-
sics among participants reporting intermittent (in grey) or daily mus-
culoskeletal pain (in black) in 1999, 2009, and 2019. Percentages 
were adjusted for age, sex, and Charlson comorbidity index with 95% 
confidence intervals (p < 0.001 for cohort, p < 0.001 for pain group, 
p = 0.89 for interaction). n = 2473, n = 1583, and n = 1651 in 1999, 
2009, and 2019, respectively
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the prevalence of opioid use has been increasing in Finn-
ish long-term care settings [30], it is reassuring to observe 
that opioids are not regularly used by a larger proportion of 
community-dwelling older persons in our study population.
This study had several strengths. First, we studied and 
compared relatively large cross-sectional community-dwell-
ing cohorts that were retrieved from an equivalent popula-
tion at three time points, thus enabling time-trend analysis. 
Second, the questions were the same and the response rate 
remained good in all study waves. Third, the recall time of 
2 weeks is likely to be reliable when assessing pain [3]. 
Fourth, self-reported use of analgesics may provide more 
reliable information on regular drug use than from pharmacy 
records only.
This study had some weaknesses. First, we did not exam-
ine pain intensity. Also, the 2-week period can be considered 
short to examine pain. However, it gives a good estimate of 
pain prevalence at a population level. Second, use of over-
the-counter medicines or pro re nata drugs was not exam-
ined, which might underestimate analgesic use. Third, we 
did not address non-pharmacological treatments that are 
considered essential for pain management in the older pop-
ulation. Lastly, our cohort data were cross-sectional; thus, 
we could not assess causality or temporal interdependence 
between pain and analgesic medication. Our cohort data 
consists of community-dwelling older adults in the urban 
Helsinki area. Therefore, the results may not directly apply 
to other cultural contexts or more rural populations even in 
Finland.
5  Conclusions
The prevalence of musculoskeletal pain was high in all 
study waves and did not decrease with increasing analge-
sic use. Although the use of regular prescribed analgesics 
increased from 1999 to 2019, pain remains undertreated in 
the community-dwelling older population aged >75 years. 
Over 20 years, the use of paracetamol increased while the 
use of non-selective NSAIDs decreased. We did not observe 
a major increase in regular opioid use among community-
dwelling older persons from 1999 to 2019. More studies are 
needed to explore the intensity of pain and the efficacy of 
both pharmacological and non-pharmacological approaches 
in pain management among older adults.
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